TBK1 and hepatocellular carcinoma: This study is the first to report the relationship between TBK1 and the resistance of HCC cells to molecularly targeted drugs, which not only expands our understanding of TBK1, but also provides new ideas and implications for the treatment of HCC with molecularly targeted drugs.